This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Hub and Specialty Pharmacy Models East
March 17-20, 2025
See You Next Year!Sheraton Philadelphia Downtown | Philadelphia, PA

Jan Nielsen
Division President, Patient Solutions at AssistRx
Speaker

Profile

Jan Nielsen directs strategy and operations for the AssistRx Patient Solutions portfolio, including the access and patient support services and the non-commercial pharmacy, as well as the quality and corporate training departments. In her role, she leads with more than 30 years of experience as a clinical and operational subject matter expert with a strong background in critical care, hospital management and specialty pharmaceutical commercialization services. Her proven track record driving innovation within the specialty pharmaceutical industry supports AssistRx’s unique approach to combining technology and talent to improve patient access and treatment outcomes.

Prior to joining AssistRx, Nielsen served as a senior principal at Blue Fin Group, a management and technology consulting firm with a focus on the pharmaceutical, biotechnology and healthcare industries. Prior to Blue Fin Group, Nielsen was the division president of access and patient support for Sonexus, a Cardinal Health company, where she founded and launched the patient support services business unit. Her industry leadership also includes leading the development and launch of the clinical support division of AmerisourceBergen that now resides with Lash Group.

Nielsen earned a bachelor’s degree in human services from Notre Dame de Namur University. She received her nursing degree from the U.S. Army School of Nursing.

Agenda Sessions

  • Real-life Use Cases You Can Apply to Your Patient Support Strategy

    11:00am
  • [**Industry Only Solution Summit] Hear from Your Peers – Tackling 2024's Biggest Market Challenges

    3:45pm